By Michael Li
China has announced measures allowing eligible foreign physicians to obtain permits to provide clinical diagnosis and treatment services in Hainan for up to three years. The measures, made public on October 29, 2026, also provide for extensions under applicable regulations and further facilitation of foreign nationals’ work permits, stay and residence arrangements.
For healthcare institutions and overseas medical professionals, the development creates a longer potential planning horizon. The permitted duration of clinical practice should nevertheless be assessed separately from the immigration and employment arrangements required for a particular appointment.
The physician provision forms part of a package of 16 measures covering foreign business and professional activity in the Hainan Free Trade Port.
According to the official announcement, the provision concerns foreign physicians who are legally entitled to practise medicine overseas. The stated maximum period is three years; it should not be presented as an automatic three-year approval for every applicant.
The announcement establishes the policy direction. Institutions planning appointments should confirm the applicable application arrangements, permitted activities and supporting documentation with the responsible authorities.
China’s official guide to working and living in the country treats work authorisation and residence procedures as distinct administrative matters. A medical institution should therefore avoid using the duration stated in a clinical practice permit as the sole basis for a foreign physician’s employment or residence timetable.
As a practical planning measure, the institution and physician should establish:
Which professional authorisation applies to the proposed clinical activities.
Which work and immigration arrangements apply to the appointment.
Whether the relevant permissions cover the intended location and period.
Who will monitor expiry dates and prepare extension applications.
These checks are particularly relevant where recruitment, patient scheduling and relocation commitments are being arranged together.
Boao Lecheng illustrates the existing scale of Hainan’s medical tourism sector.
A report published on the Chinese government’s English-language website on January 17, 2025 recorded 413,700 medical tourism visitors in Lecheng during 2024, representing 36.76% year-on-year growth. It also reported 36 operational medical institutions.
These figures predate the October 2026 measures. They provide historical market context, rather than evidence of results produced by the new physician policy.
For institutions considering expansion, professional recruitment and institutional branding also require separate planning. An international provider introducing a local trading name may need to review its Chinese brand-name protection alongside its operational preparations.
No. Three years is the announced maximum duration. Eligibility, approval conditions and the period granted require confirmation through the applicable process.
No such equivalence should be assumed. The professional, employment and immigration arrangements should each be checked for the individual appointment.
No. The figures concern 2024 and were reported in January 2025, before the October 2026 announcement.
Healthcare organisations entering China may also need to protect their institutional names, Chinese-language brands and service identities. IPcrossark’s China trademark services provide a starting point for enquiries about trademark searches and applications.
This brand-protection work is separate from professional licensing and immigration procedures.
Fields marked * are required. We usually reply within one business day.
We will reply by email within one business day. This window will close automatically.
